Mylan NV (NASDAQ:MYL)

22.14
Delayed Data
As of 4:00pm ET
 +0.35 / +1.61%
Today’s Change
16.63
Today|||52-Week Range
32.23
+10.15%
Year-to-Date
Pfizer to Market Viagra Through Roman's Telehealth Service
10:36am / MotleyFool.com - Paid Partner Content
Is Pfizer's Stock a Buy?
Jan 14 / MotleyFool.com - Paid Partner Content
2 Biotechs Battling Immune Diseases
Jan 19 / MotleyFool.com - Paid Partner Content
Here's Why Mylan Fell 26.6% in 2019
Jan 10 / MotleyFool.com - Paid Partner Content
Will Theravance Biopharma Finally Break Out in 2020?
Jan 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close21.79
Today’s open21.64
Day’s range21.39 - 22.28
Volume4,799,337
Average volume (3 months)6,202,830
Market cap$11.2B
Data as of 4:00pm ET, 01/23/2020

Growth & Valuation

Earnings growth (last year)-46.92%
Earnings growth (this year)-6.02%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)-4.02%
P/E ratio246.0
Price/Sales1.24
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
BHCValeant Pharmaceutic...-0.32-1.08%
ALNYAlnylam Pharmaceutic...+2.33+2.02%
CTLTCatalent Inc-0.18-0.29%
SRPTSarepta Therapeutics...-4.65-3.93%
Data as of 6:30pm ET, 01/23/2020

Financials

Next reporting dateFebruary 26, 2020
EPS forecast (this quarter)$1.28
Annual revenue (last year)$11.4B
Annual profit (last year)$352.5M
Net profit margin3.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Hatfield, Hertfordshire

Forecasts